Repaglinide IP 1 mg Tablets are oral antidiabetic medicines used to control Type 2 Diabetes Mellitus. Repaglinide belongs to the meglitinide class of insulin secretagogues, which act by stimulating the pancreas to release insulin in response to meals. This helps reduce blood sugar spikes after eating and supports overall glycemic control. Manufactured by Globus Labs, this formulation is suitable as monotherapy or in combination with other diabetes medicines.
Repaglinide IP (1 mg): A short-acting oral antidiabetic that works by increasing insulin secretion from pancreatic beta cells. It effectively controls blood glucose after meals and helps maintain stable sugar levels throughout the day.
Post-Meal Sugar Control: Prevents sharp rises in blood sugar levels after eating.
Stimulates Insulin Production: Encourages the pancreas to release insulin when needed.
Supports Glycemic Stability: Helps maintain healthy fasting and postprandial glucose.
Flexible and Safe: Can be used alone or with other antidiabetic agents under medical supervision.
Reduces Diabetes Complications: Helps prevent kidney, nerve, and eye damage caused by uncontrolled diabetes.
Take Repaglinide 1 mg Tablets orally before meals, or as prescribed by your healthcare provider. Swallow the tablet whole with water. Regular diet control and exercise are recommended for best results.
Mild side effects may include headache, dizziness, nausea, stomach discomfort, or low blood sugar (hypoglycemia). Most effects are temporary. Contact your doctor if they persist.
Globus Labs brings you WHO-GMP–certified, high-quality Repaglinide IP 1 mg sourced from reputed pharmaceutical manufacturers. Ripadep-1 is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.